Side-by-side comparison of AI visibility scores, market position, and capabilities
Employee lifestyle benefits and stipend management platform helping companies offer personalized, tax-compliant perks programs.
Compt is a Boston-based stipend management platform that enables employers to offer personalized, flexible employee benefits through customizable perk stipends. Founded in 2018, the company built its product around the insight that traditional benefit packages fail to address the diversity of employee needs across different life stages, geographies, and personal priorities. HR teams use Compt to create multiple stipend categories—health and wellness, learning and development, remote work, family, and more—each with configurable budgets, eligibility windows, and approved vendor lists. Employees submit reimbursement requests through a simple mobile or web interface, and Compt handles the tax compliance and payroll reporting automatically.\n\nA core differentiator for Compt is its focus on IRS tax compliance for employer-funded perks. The platform automatically categorizes taxable versus non-taxable stipends, generates accurate payroll additions for W-2 reporting, and provides audit-ready documentation—a pain point that many HR teams struggle with when running manual reimbursement programs. This compliance infrastructure has made Compt particularly attractive to finance-conscious mid-market companies that want to expand their benefits footprint without creating accounting complexity.\n\nCompt serves hundreds of companies across technology, professional services, and healthcare sectors. Its customer base skews toward companies with 50 to 1,000 employees that are scaling quickly and competing for talent against larger enterprises with richer traditional benefit packages. The platform integrates with major HRIS and payroll tools including Gusto, Rippling, and ADP, and offers real-time reporting dashboards that give HR leaders visibility into stipend utilization and employee engagement trends.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.